Skip Navigation LinksHome > July-September 2013 - Volume 27 - Issue 3 > Rivastigmine in the Treatment of Hypersexuality in Alzheimer...
Alzheimer Disease & Associated Disorders:
doi: 10.1097/WAD.0b013e31825c85ae
Case Report

Rivastigmine in the Treatment of Hypersexuality in Alzheimer Disease

Canevelli, Marco MD; Talarico, Giuseppina MD, PhD; Tosto, Giuseppe MD; Troili, Fernanda; Lenzi, Gian Luigi MD; Bruno, Giuseppe MD, PhD

Collapse Box


Inappropriate sexual behaviors (ISB) represent uncommon and often misdiagnosed clinical disorders among patients with Alzheimer disease. So far, no randomized clinical trials regarding the treatment of ISB in demented people have been conducted, but available data from case series and isolated case reports suggest the efficacy of selective serotonin reuptake inhibitors (SSRIs), antipsychotics, antiandrogens, and H2-receptor antagonists. Controversial data exist on the therapeutic influence of cholinesterase inhibitors on sexual disorders. In the present article, we describe the case of an Alzheimer disease patient presenting hypersexuality, successfully treated with rivastigmine. Thus, we perform a revision of the existing literature regarding the therapeutical effect of cholinesterase inhibitors in the treatment of ISB.

© 2013 by Lippincott Williams & Wilkins.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.